Introduction

Liposomes and nanosomes are at the forefront of advanced drug delivery systems, offering targeted, controlled, and sustained release of therapeutic agents. To ensure these nanoscale carriers perform as intended, accurate particle characterization is crucial. Accuprec Research Labs specializes in the detailed physicochemical characterization of liposomal and nanosomal formulations to meet quality, safety, and efficacy benchmarks.

Why Particle Characterization Matters

• Ensures batch-to-batch consistency and product reproducibility
• Optimizes stability, encapsulation efficiency, and release profiles
• Supports regulatory compliance with international standards

Accuprec’s Capabilities

Our nanotechnology characterization laboratory offers a full suite of analytical testing for liposomes and nanosomes, including:

• Particle Size Distribution (PSD) – Dynamic Light Scattering (DLS)
• Zeta Potential Measurement – Surface charge and stability evaluation
• Polydispersity Index (PDI) – Uniformity and dispersion analysis
• Encapsulation Efficiency – Quantifying active ingredient retention
• In-vitro Release Studies – Controlled release evaluation
• Microscopy (SEM/TEM) – Morphological and structural assessment

Regulatory Standards

Our testing protocols adhere to international guidelines, including:

• ICH Q6A: Specifications for new drug substances and products
• OECD GLP standards for analytical testing
• FDA and EMA regulatory frameworks for nanomedicines

Meet Us at CPHI Frankfurt 2025

Visit Stall D96 | Hall 6.1 at Messe Frankfurt, Germany, to explore how Accuprec supports nanotechnology-driven innovation in pharmaceutical development through advanced liposome and nanosome characterization.